NFL Biosciences SAS (ALNFL) — Free Cash Flow Generation Index
NFL Biosciences SAS (ALNFL) has a Free Cash Flow Generation Index of 1.00x as of June 2023. Free cash flow of €57.51K represents 1% of operating cash flow (€57.51K). See NFL Biosciences SAS short-term liquidity ratio to evaluate short-term liquidity relative to the company's equity base.
FCF Generation Index
Free Cash Flow
Operating Cash Flow
Capital Expenditures
NFL Biosciences SAS Free Cash Flow Generation Index (2020–2022)
Historical FCF Generation Index trend for NFL Biosciences SAS across 3 annual periods. Explore ALNFL cash flow to debt ratio to assess how comfortably operating cash covers total debt obligations.
Annual Free Cash Flow Generation for NFL Biosciences SAS (2020–2022)
Year-by-year Free Cash Flow Generation Index for NFL Biosciences SAS. For the full company profile including market capitalisation, see ALNFL stock market capitalisation.
| Year | FCG Index | Free Cash Flow (EUR) | Operating CF | Capital Expenditures | YoY Change |
|---|---|---|---|---|---|
| 2022 | 1.00x | €104.89K | €104.89K | €0.00 | ▲ +0.0% |
| 2021 | 1.00x | €87.00K | €87.00K | €0.00 | ▲ +0.0% |
| 2020 | 1.00x | €83.91K | €83.91K | €0.00 | — |